How can a practicing urologist prevent adverse drug interactions?
https://doi.org/10.21518/2079-701X-2014-19-32-35
Abstract
Today it is difficult to think of a clinician who does not utilize a multitude of pharmacotherapeutic options. The modern clinical pharmacology has significantly expanded the opportunities for conservative, medicinal treatment of diseases for which surgery was the only method of cure in the past. The growth in the arsenal of drugs, however, often results in prescription of a multitude of drugs at the same time. It becomes increasingly important therefore to assess drug interactions to enhance efficacy of treatment and prevention of adverse reactions.
About the Authors
SK Ziryanov
Pirogov Russian National Research Medical University, Russia’s Ministry of Health, Moscow
Russian Federation
Russian Federation
YB Belousov
Pirogov Russian National Research Medical University, Russia’s Ministry of Health, Moscow
Russian Federation
Russian Federation
References
1. Урология. Фармакотерапия без ошибок. Руководство для врачей. Под ред. акад. РАМН. Н.А. Лопаткина. Е-ното, 2012.
2. Schwinn DA, Michelotti GA. aj-adrenergic receptors in the lower urinary tract and vascular bed: potential role for the a1d-subtype in filling symptoms and effects of ageing on vascular expression. BJUInt, 2000, 85 (suppl. 2): 6-11.
3. McConell ID, Roeborn CG, Bautista OM et al. The long-term effect of doxazozine, finasteride, and combination therapy on the clinical progression of bening prostatic hyperplasia. N Engl. J. Med, 2003, 349: 2387-98.
4. Lepor H. Long-term efficacy and safety of terazosin in patients with bening prostatic hyperplasia. Terazosin Research Group. Urology, 1995, 45: 406-13.
5. Boyle P, Napalkov P The epidemiology of bening prostate hyperplasia and observations on concomitant hypertension Scand.J. Urol. Nephrol., 1995, Suppl. 168: 7-12. '
6. Манешина О.А., Белоусов Ю.Б. Полипрагмазия и лекарственные взаимодействия у пожилых пациентов. Качественная клиническая практика, 2008, 3: 90-93.
7. Troost J, Tatami S, Tsuda Y et al. Effects of strong CYP2D6 and 3A4 unhibitors, paroxetine and ketoconazole, on the pharmacokinetics and cardiovascular safety of tamsulosin. Br.J. Clin. Pharmacol., 2011, 72 (2): 247-256.
8. Guillaume M, Lonsdale F, Darstein C et al. Hemodynamic interaction between a daily dosed phosphodiesterase 5 inhibitor, tadalafil, and the alpha-adrenergic blockers, doxazosin and tamsulosin, in middle-aged healthy male subjects. J. Clin. Pharmacol., 2007, 47 (10): 1303-1310.
9. Kim MG, Kim JR, Kim BH et al. The effect of udenafil on the hemodynamic of healthy male volunteers administered tamsulosin. Curr. Med. Res. Opin., 2013, 29 (6): 685-693.
Review
For citations:
Ziryanov S, Belousov Y. How can a practicing urologist prevent adverse drug interactions? Meditsinskiy sovet = Medical Council. 2014;(19):32-35. (In Russ.) https://doi.org/10.21518/2079-701X-2014-19-32-35
Views:
375
Email this article 